Affiliations 

  • 1 Departments of Medicine and Neurology, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia
  • 2 Department of Neurosciences, College of Medicine-Philippine General Hospital, The Health Sciences Center, University of the Philippines Manila, Manila, Philippines
  • 3 Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Fitzroy, Victoria, Australia
  • 4 Indian Epilepsy Centre, New Delhi, India and Asian Institue of Medical Sciences, Faridabad, India
  • 5 Department of Neurology, Yonsei University College of Medicine, Seoul, Korea
  • 6 Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China
  • 7 National Neuroscience Institute, Singapore General Hospital, Duke-National University of Singapore-Graduate Medical School, Singapore, Singapore
  • 8 Department of Neurosurgery, National Center of Neurology and Psychiatry, Tokyo, Japan
  • 9 Division of Neurology, University of Malaya, Kuala Lumpur, Malaysia
  • 10 Department of Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan
Epilepsia, 2015 May;56(5):667-73.
PMID: 25823580 DOI: 10.1111/epi.12957

Abstract

The Asia-Oceanian region is the most populous region in the world. Although there has been substantial economic development and improvement in health services in recent years, epilepsy remains generally an underrecognized and understudied condition. To help promote research in the region, the Commission on Asian and Oceanian Affairs (CAOA) of the International League Against Epilepsy (ILAE) appointed the Research Task Force (RTF) to facilitate the development of research priorities for the region. Research that focuses on issues that are unique or of particular importance in the Asia-Oceanian region is encouraged, and that captures the impact of the dynamic socioeconomic changes taking place in the region is emphasized. Based on these considerations, we propose research "dimensions" as priorities within the Asia-Oceanian region. These are studies (1) that would lead to fuller appreciation of the health burden of epilepsy, particularly the treatment gap; (2) that would lead to better understanding of the causes of epilepsy; (3) that would alleviate the psychosocial consequences of epilepsy; (4) that would develop better therapies and improved therapeutic outcomes; and (5) that would improve the research infrastructure.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.